全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Basedowian Orbitopathy without Thyreotoxicosis: A Case Report from Sikasso Hospital

DOI: 10.4236/ojoph.2023.133026, PP. 273-279

Keywords: Euthyroidism, Basedowian Orbitopathy, Orbital-Cerebral, MRI, Corticosteroid Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Basedowian orbitopathy is an autoimmune disease representing the most frequent extra-thyroidal manifestation. Its pathophysiology is imperfectly elucidated and is the result of cross-reactivity between thyroid antigens and orbital tissue. It is most frequently seen in the context of hyperthyroidism (basedow’s disease or Graves’ disease), sometimes hypothyroidism (Hashimoto’s thyroiditis), or euthyroidism. Diagnosis is often straightforward, but management remains difficult. The introduction of simple medical treatment exposes the patient to the risk of recurrence. In Sikasso, there have been few studies of Graves’ disease. The aim of this study was to describe the clinical, therapeutic and evolutionary features of Graves’ disease in Sikasso Hospital. The patient was a 35-year-old woman with no previous history of Graves’ disease and no history of alcohol or tobacco intoxication, consulting for bilateral exophthalmos with moderate pain for 1 year. Endocrine tests were normal (euthyroidism), as was orbital-cerebral MRI, which revealed stage II exophthalmos with no sellar or supra-saltar abnormalities. The main complication was exposure to keratitis. Our patient was treated with corticosteroids. The evolution was favorable under treatment, with no recurrence after one year’s follow-up. Graves’ disease is the most common cause of hyperthyroidism, but this should not obscure the diagnosis of euthyroidism, as demonstrated in this case report. Exophthalmos remains the main ophthalmological clinical manifestation.

References

[1]  Hamédani, M. and Obéric, A. (2013) Dysthyroid Orbitopathy: From Diagnosis to Treatment. Revue Médicale Suisse, 9, 66-71.
[2]  Yanoff, M. and Duker, J.S. (2018) Ophthalmology. 5th Edition, Elsevier Masson, Paris.
[3]  Mbarek, S., Abid, F., Ammari, W., Alaya, W., Mahmoud, A. and Messaoud, R. (2021) Basedowian Orbitopathy: About 82 Cases. Tunisie Medicale, 99, 243-251.
[4]  Jenouiz, Z., Jaidane, A., Riahi, M., Zouaoui, C. and Ouertani, H. (2018) Orbitopathie sévère dans le cadre d’un syndrome de Means: A propos d’un cas [Severe Orbitopathy in the Context of Means Syndrome: About a Case]. Annales d’Endocrinologie, 79, 386. https://doi.org/10.1016/j.ando.2018.06.607
[5]  Koumaré, A.K., Sissoko, F., Ongoiba, N., Bereté, S., Traoré Diop, A.K., Bagayogo, T.B., Doumbia, D., Coulibaly, Y., Sidibé-Traoré, A., Dembelé, M., Traoré, H.A. and Bayo, S. (2002) Goitres bénins en chirurgie au Mali (à propos de 815 cas) [Benign Goiters in Surgery in Mali (about 815 Cases)]. E-mémoires de l’Académie Nationale de Chirurgie, 1, 1-6.
[6]  Diagne, N., Faye, A., Ndao, A.C., Djiba, B., Kane, B.S., Ndongo, S. and Pouye, A. (2016) Epidemiological, Clinical, Therapeutic and Evolutionary Aspects of Basedow— Graves’ Disease in Internal Medicine at CHU Le dantec, Dakar (Senegal). The Pan African Medical Journal, 25. https://doi.org/10.11604/pamj.2016.25.6.7868
[7]  Brah, S., et al., (2016) Dysthyroidism in the Internal Medicine Department of the National Hospital of Niamey, Niger. Health Sciences and Disease, 17, 36-40.
[8]  Daldoul, N., Knani, L., Gatfaoui, F. and Mahjoub, H. (2017) Prise en charge des orbitopathies dysthyroidiennes modérées et sévères: A propos de 22 cas [Management of Moderate and Severe Dysthyroid Orbitopathies: About 22 Cases]. The Pan African Medical Journal, 27, Article 257.
https://doi.org/10.11604/pamj.2017.27.257.13008
[9]  Retout, A. (2005) Severe Basedowian Exophthalmos—Graves Severe Ophthal-mopathy. Metabolisms Hormones Diabetes and Nutrition, 9, 124-126.
[10]  Morax, S. and Badelon, I. (2009) Basedowian Exophthalmia. French Journal of Ophthalmology, 32, 589-599. https://doi.org/10.1016/j.jfo.2009.09.001
[11]  Vignal-Clermont, C. and Badelon, I. (2012) Graves’ Disease and Ophthalmology: The Essential Points. International Ophthalmology, 1, 68-71.
[12]  Strianese, D. (2017) Update on Graves’ Disease: Advances in Treatment of Mild, Moderate And Severe Thyroid Eye Disease. Current Opinion in Ophthalmology, 28, 505-513. https://doi.org/10.1097/ICU.0000000000000402
[13]  Jang, S.Y., Lee, S.Y., Lee, E.J. and Yoon, J.S. (2012) Clinical Features of Thyroid-Associated Ophthalmopathy in Clinically Euthyroid Korean Patients. Eye (London), 26, 1263-1269. https://doi.org/10.1038/eye.2012.132

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133